Your browser doesn't support javascript.
loading
Mesenchyme-derived IGF2 is a major paracrine regulator of pancreatic growth and function.
Hammerle, Constanze M; Sandovici, Ionel; Brierley, Gemma V; Smith, Nicola M; Zimmer, Warren E; Zvetkova, Ilona; Prosser, Haydn M; Sekita, Yoichi; Lam, Brian Y H; Ma, Marcella; Cooper, Wendy N; Vidal-Puig, Antonio; Ozanne, Susan E; Medina-Gómez, Gema; Constância, Miguel.
Afiliação
  • Hammerle CM; University of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Institute of Metabolic Science, Addenbrookes Hospital, Cambridge, United Kingdom.
  • Sandovici I; Department of Obstetrics and Gynaecology and National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, United Kingdom.
  • Brierley GV; University of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Institute of Metabolic Science, Addenbrookes Hospital, Cambridge, United Kingdom.
  • Smith NM; Department of Obstetrics and Gynaecology and National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, United Kingdom.
  • Zimmer WE; Centre for Trophoblast Research, Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, United Kingdom.
  • Zvetkova I; University of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Institute of Metabolic Science, Addenbrookes Hospital, Cambridge, United Kingdom.
  • Prosser HM; University of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Institute of Metabolic Science, Addenbrookes Hospital, Cambridge, United Kingdom.
  • Sekita Y; Department of Obstetrics and Gynaecology and National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, United Kingdom.
  • Lam BYH; Department of Medical Physiology, Texas A&M Health Science Center, College Station, Texas, United States of America.
  • Ma M; University of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Institute of Metabolic Science, Addenbrookes Hospital, Cambridge, United Kingdom.
  • Cooper WN; The Wellcome Trust Sanger Institute, Genome Campus, Hinxton, United Kingdom.
  • Vidal-Puig A; University of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Institute of Metabolic Science, Addenbrookes Hospital, Cambridge, United Kingdom.
  • Ozanne SE; University of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Institute of Metabolic Science, Addenbrookes Hospital, Cambridge, United Kingdom.
  • Medina-Gómez G; University of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Institute of Metabolic Science, Addenbrookes Hospital, Cambridge, United Kingdom.
  • Constância M; University of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Institute of Metabolic Science, Addenbrookes Hospital, Cambridge, United Kingdom.
PLoS Genet ; 16(10): e1009069, 2020 10.
Article em En | MEDLINE | ID: mdl-33057429
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pâncreas / Fator de Crescimento Insulin-Like II / Comunicação Parácrina / Mesoderma Tipo de estudo: Prognostic_studies Limite: Animals / Pregnancy Idioma: En Revista: PLoS Genet Assunto da revista: GENETICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pâncreas / Fator de Crescimento Insulin-Like II / Comunicação Parácrina / Mesoderma Tipo de estudo: Prognostic_studies Limite: Animals / Pregnancy Idioma: En Revista: PLoS Genet Assunto da revista: GENETICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido